Axonics Modulation Technologies Stock Total Asset
| AXNXDelisted Stock | USD 70.98 0.48 0.68% |
Axonics Modulation Technologies fundamentals help investors to digest information that contributes to Axonics Modulation's financial success or failures. It also enables traders to predict the movement of Axonics Stock. The fundamental analysis module provides a way to measure Axonics Modulation's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Axonics Modulation stock.
Axonics |
Axonics Modulation Technologies Company Total Asset Analysis
Axonics Modulation's Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.
Current Axonics Modulation Total Asset | 719.92 M |
Most of Axonics Modulation's fundamental indicators, such as Total Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Axonics Modulation Technologies is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Total Asset is typically divided on the balance sheet on current asset and long-term asset. Long-term is the value of company property and other capital assets that are expected to be useable for more than one year. Long term assets are reported net of depreciation. On the other hand current assets are assets that are expected to be sold or converted to cash as part of normal business operation.
CompetitionBased on the latest financial disclosure, Axonics Modulation Technologies has a Total Asset of 719.92 M. This is 90.43% lower than that of the Health Care Equipment & Supplies sector and 88.6% lower than that of the Health Care industry. The total asset for all United States stocks is 97.56% higher than that of the company.
Axonics Total Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Axonics Modulation's direct or indirect competition against its Total Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Axonics Modulation could also be used in its relative valuation, which is a method of valuing Axonics Modulation by comparing valuation metrics of similar companies.Axonics Modulation is currently under evaluation in total asset category among its peers.
Axonics Fundamentals
| Return On Equity | -0.0089 | ||||
| Return On Asset | -0.0063 | ||||
| Profit Margin | (0.01) % | ||||
| Operating Margin | (0.02) % | ||||
| Current Valuation | 3.32 B | ||||
| Shares Outstanding | 51.11 M | ||||
| Shares Owned By Insiders | 1.26 % | ||||
| Shares Owned By Institutions | 87.22 % | ||||
| Number Of Shares Shorted | 3.31 M | ||||
| Price To Earning | (10.68) X | ||||
| Price To Book | 5.46 X | ||||
| Price To Sales | 8.40 X | ||||
| Revenue | 366.38 M | ||||
| Gross Profit | 197.66 M | ||||
| EBITDA | 7.78 M | ||||
| Net Income | (6.09 M) | ||||
| Cash And Equivalents | 213.23 M | ||||
| Cash Per Share | 4.53 X | ||||
| Total Debt | 27.62 M | ||||
| Debt To Equity | 0.02 % | ||||
| Current Ratio | 10.49 X | ||||
| Book Value Per Share | 13.00 X | ||||
| Cash Flow From Operations | (2.02 M) | ||||
| Short Ratio | 7.14 X | ||||
| Earnings Per Share | (0.10) X | ||||
| Price To Earnings To Growth | (0.56) X | ||||
| Target Price | 72.0 | ||||
| Number Of Employees | 797 | ||||
| Beta | 0.83 | ||||
| Market Capitalization | 3.63 B | ||||
| Total Asset | 719.92 M | ||||
| Retained Earnings | (380.35 M) | ||||
| Working Capital | 445.61 M | ||||
| Current Asset | 171.14 M | ||||
| Current Liabilities | 12.98 M | ||||
| Net Asset | 719.92 M |
About Axonics Modulation Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Axonics Modulation Technologies's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Axonics Modulation using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Axonics Modulation Technologies based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Other Consideration for investing in Axonics Stock
If you are still planning to invest in Axonics Modulation check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Axonics Modulation's history and understand the potential risks before investing.
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |